HUM vs PCSA · P/E 39, rev $117.76B vs $5.9M cap
Humana Inc (HUM) versus Processa Pharmaceuticals Inc (PCSA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported PCSA revenue for 2023-09-30 was $0. Net income was -$2.1M. PCSA currently screens at market cap $5.9M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. PCSA currently screens at market cap $5.9M.
Not investment advice. Open the HUM and PCSA stock pages for the full models.
Not investment advice.